Stocks Overview

LAST PRICE
31.9500
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
---/ ---
Ask / Lots
---/ ---
Open / Previous Close
0.0000 / 31.9500
Day Range
---
52 Week Range
Low 13.5700
High 53.0800
Volume
---
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 32.37
Time	Volume	ARVN
09:32 ET	2950	32.89
09:34 ET	500	32.5548
09:36 ET	2300	32.15
09:38 ET	3030	32.247
09:45 ET	500	32.375
09:48 ET	900	32.385
09:50 ET	1582	32.335
09:52 ET	2100	32.2929
09:54 ET	1200	32.29
09:57 ET	100	32.2
09:59 ET	200	32.245
10:01 ET	1300	32.55
10:03 ET	600	32.5
10:06 ET	200	32.5
10:08 ET	700	32.67
10:10 ET	100	33
10:12 ET	600	33.075
10:14 ET	1844	33.15
10:15 ET	600	33.11
10:17 ET	800	33.17
10:19 ET	2137	33.02
10:21 ET	910	32.85
10:24 ET	100	32.84
10:28 ET	500	32.775
10:30 ET	100	32.7
10:32 ET	2516	32.855
10:33 ET	200	32.87
10:35 ET	104	32.83
10:37 ET	100	32.87
10:39 ET	1550	32.865
10:42 ET	100	32.83
10:44 ET	700	32.8073
10:46 ET	500	32.7671
10:48 ET	600	32.79
10:50 ET	100	32.77
10:51 ET	400	32.74
10:53 ET	500	32.71
10:55 ET	1772	32.825
11:00 ET	2416	32.81
11:02 ET	100	32.77
11:04 ET	200	32.78
11:06 ET	100	32.76
11:08 ET	1126	32.74
11:09 ET	450	32.67
11:11 ET	2531	32.82
11:13 ET	100	32.835
11:15 ET	954	32.88
11:18 ET	500	32.98
11:20 ET	1526	32.9
11:22 ET	400	32.96
11:26 ET	1500	32.8
11:27 ET	700	32.69
11:29 ET	1400	32.52
11:31 ET	888	32.515
11:33 ET	200	32.6
11:36 ET	600	32.72
11:40 ET	300	32.745
11:42 ET	600	32.68
11:44 ET	961	32.7116
11:45 ET	100	32.73
11:47 ET	587	32.8
11:49 ET	2000	32.75
11:51 ET	200	32.71
11:54 ET	100	32.695
11:56 ET	700	32.785
11:58 ET	100	32.85
12:00 ET	600	32.82
12:02 ET	500	32.79
12:03 ET	800	32.78
12:07 ET	400	32.87
12:09 ET	200	32.905
12:12 ET	100	32.93
12:16 ET	300	32.915
12:18 ET	1715	32.835
12:23 ET	300	32.84
12:25 ET	333	32.86
12:27 ET	1000	32.82
12:30 ET	810	32.81
12:32 ET	900	32.785
12:34 ET	2200	32.755
12:36 ET	800	32.86
12:38 ET	400	32.87
12:39 ET	100	32.87
12:41 ET	2000	32.81
12:48 ET	890	32.7
12:50 ET	200	32.77
12:54 ET	400	32.77
12:57 ET	600	32.7896
01:01 ET	796	32.75
01:03 ET	700	32.82
01:06 ET	900	32.83
01:08 ET	300	32.84
01:10 ET	463	32.81
01:12 ET	300	32.83
01:14 ET	100	32.84
01:15 ET	900	32.81
01:21 ET	1291	32.785
01:26 ET	400	32.81
01:28 ET	900	32.81
01:30 ET	300	32.855
01:32 ET	500	32.82
01:33 ET	400	32.84
01:35 ET	800	32.91
01:37 ET	1376	32.94
01:39 ET	100	32.915
01:44 ET	200	32.95
01:46 ET	964	32.88
01:50 ET	300	32.85
01:53 ET	100	32.855
01:55 ET	100	32.83
01:57 ET	100	32.85
02:00 ET	1600	32.875
02:02 ET	2610	32.8
02:06 ET	200	32.79
02:08 ET	700	32.72
02:11 ET	236	32.67
02:18 ET	600	32.62
02:20 ET	1213	32.65
02:24 ET	400	32.65
02:26 ET	1391	32.68
02:27 ET	800	32.68
02:29 ET	900	32.61
02:31 ET	100	32.57
02:33 ET	200	32.57
02:36 ET	100	32.55
02:38 ET	2625	32.62
02:40 ET	1352	32.57
02:42 ET	200	32.57
02:47 ET	1957	32.515
02:51 ET	100	32.53
02:54 ET	600	32.585
02:56 ET	700	32.54
03:00 ET	800	32.59
03:02 ET	2351	32.55
03:03 ET	836	32.48
03:05 ET	1900	32.5
03:07 ET	400	32.52
03:09 ET	100	32.525
03:12 ET	1133	32.51
03:14 ET	100	32.48
03:18 ET	200	32.39
03:20 ET	386	32.34
03:21 ET	900	32.34
03:23 ET	200	32.31
03:25 ET	1050	32.26
03:27 ET	2726	32.33
03:30 ET	1334	32.314
03:32 ET	700	32.34
03:34 ET	2268	32.4
03:36 ET	2299	32.36
03:38 ET	1560	32.36
03:39 ET	3252	32.4
03:41 ET	400	32.39
03:43 ET	2011	32.321
03:45 ET	2543	32.29
03:48 ET	1500	32.28
03:50 ET	760	32.25
03:52 ET	3481	32.25
03:54 ET	2809	32.27
03:56 ET	8161	32.16
03:57 ET	24293	32
03:59 ET	85556	31.95

Data delayed at least 15 minutes.

Yesterday
- Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress, from 10 hours ago by Dow Jones
  10 hours ago by Dow Jones
- DJ Arvinas Is Maintained at Overweight by Wells Fargo, from 15 hours ago by Dow Jones
  15 hours ago by Dow Jones
May 8, 2024
- DJ Arvinas Price Target Maintained With a $57.00/Share by Wedbush, from 10:27AM ET on Wednesday May 08, 2024 by Dow Jones
  10:27AM ET on Wednesday May 08, 2024 by Dow Jones
- DJ Arvinas Is Maintained at Buy by Stifel, from 9:37AM ET on Wednesday May 08, 2024 by Dow Jones
  9:37AM ET on Wednesday May 08, 2024 by Dow Jones
- DJ Arvinas Price Target Maintained With a $87.00/Share by HC Wainwright & Co., from 9:03AM ET on Wednesday May 08, 2024 by Dow Jones
  9:03AM ET on Wednesday May 08, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesARVN Arvinas Inc	2.2B	-5.3x	---
United StatesRYTM Rhythm Pharmaceuticals Inc	2.3B	-8.3x	---
United StatesKYMR Kymera Therapeutics Inc	2.4B	-15.4x	---
United StatesRXRX Recursion Pharmaceuticals Inc	2.1B	-5.3x	---
United StatesNTLA Intellia Therapeutics Inc	2.4B	-4.6x	---
United StatesRCKT Rocket Pharmaceuticals Inc	2.1B	-8.1x	---
As of 2024-05-10

Arvinas, Inc. is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The Company uses its PROTAC Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. It has four investigational clinical-stage programs: vepdegestrant (ARV-471) for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-766 and bavdegalutamide for the treatment of men with metastatic castration-resistant prostate cancer, and ARV-102 for the treatment of patients with neurodegenerative disorders. Its product candidate, ARV-393, is designed to target the B-cell lymphoma 6, or BCL6 protein.

Contact Information

Headquarters: 5 Science ParkNEW HAVEN, CT, United States 06511-1966
Phone: 203-535-1456
Fax: 302-636-5454

Executives

Chairman of the Board, President, Chief Executive Officer: John Houston
Interim Chief Financial Officer, Chief Business Officer, Treasurer: Randy Teel
Chief Scientific Officer: Ian Taylor
General Counsel: Jared Freedberg
Chief Medical Officer: Noah Berkowitz

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$2.2B
Revenue (TTM)	$71.3M
Shares Outstanding	68.3M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.99
EPS	$-6.05
Book Value	$9.71
P/E Ratio	-5.3x
Price/Sales (TTM)	30.6
Price/Cash Flow (TTM)	---
Operating Margin	-556.94%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Arvinas Inc
NASDAQ:ARVNUnited States

Search Criteria

Charts

Recent News

Yesterday

Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress, from 10 hours ago by Dow Jones

DJ Arvinas Is Maintained at Overweight by Wells Fargo, from 15 hours ago by Dow Jones

May 8, 2024

DJ Arvinas Price Target Maintained With a $57.00/Share by Wedbush, from 10:27AM ET on Wednesday May 08, 2024 by Dow Jones

DJ Arvinas Is Maintained at Buy by Stifel, from 9:37AM ET on Wednesday May 08, 2024 by Dow Jones

DJ Arvinas Price Target Maintained With a $87.00/Share by HC Wainwright & Co., from 9:03AM ET on Wednesday May 08, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar